Optimization of Hydrolysate-Free Media Composition and Feeding Strategy for Antibody Production through Nutrient Monitoring

Wednesday, November 11, 2009
Ryman Hall B1/B2 (Gaylord Opryland Hotel)

Szu-Han Wang, Late Stage Cell Culture, Genentech, South San Francisco, CA
Dacia R. Brooks, Late Stage Cell Culture, Genentech, South San Francisco, CA
Masaru Shiratori, Late Stage Cell Culture, Genentech, South San Francisco, CA
Kirin M. Jamison, Late Stage Cell Culture, Genentech, South San Francisco, CA
Martin Gawlitzek, Late Stage Cell Culture, Genentech, South San Francisco, CA

The production of antibodies using mammalian cells involves a complex balance of nutrients contained in basal media and feeds, which provide cells with metabolic energy for growth and protein production. While the addition of hydrolysates to chemically-defined media has typically improved product titer, its use is undesirable due to various risks of using undefined raw materials. These include sole-sourced raw material risk, variability among lots, and the risk of adventitious agents presented by the use of biologically-derived hydrolysates. Therefore, it is advantageous to develop hydrolysate-free media and feeds to meet antibody production needs.

A case study will be presented demonstrating the optimization of chemically-defined medium and feeds for a CHO cell line producing a monoclonal antibody. Nutrient profiles for a given cell line were optimized by modification of media and feed composition, feed timing, and feed volumes. Fed-batch experiments were conducted using 2-L bioreactor and shake flask models. Various techniques used to monitor and optimize nutrient composition to prevent depletion of important components, minimize accumulation of toxic by-products, and maximize antibody production will be discussed.

Extended Abstract: File Not Uploaded
See more of this Session: Poster Session: Bioengineering
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division